← Funding directory

Dated funding evidence

newcleo

Series B · $367m (further $85-125m raised across 2025-2026) · 2022-06-01

Reported round$367m (further $85-125m raised across 2025-2026)Series B
Disclosure date
2022-06-01
Reported currency
USD
Companies House
13274878
Evidence sources
2

Company

newcleoCH 13274878
2022-06-01Series B$367m (further $85-125m raised across 2025-2026)

Record fields

What the source states

Amounts, currency, stage and investor names are preserved as reported. No FX conversion, valuation inference or current-holding claim is added.

Round ID
FR-00417
Stage
Series B
Round name
Series B
Amount
$367m (further $85-125m raised across 2025-2026)
Lead investors
Not stated
Other investors
Qatar Investment Authority, New Enterprise Associates, Kairos, Indaco Ventures, Azimut Investments, CERN Pension Fund, Walter Tosto, Danieli & C., Cementir Holding, Orion Valves
Source layers
VC research snapshot, Live Chris T D1
Snapshot
2026-08-15

Named evidence

Source trail

This page is published only when the record has a resolved company, disclosure date, round stage and at least one retained source URL.

A 37X Ventures portfolio site

Operated by 37x Limited, a Guernsey Non Cellular Company, company number CMP76157, incorporated 18 July 2025.

Registered office: Les Echelons Court, Les Echelons, St. Peter Port, Guernsey, GY1 1AR.

Full company details